Tag: ZyCoV-D
Zydus’s two-dose Covid-19 vaccine, ZyCoV-D receives EUA from DCGI
The two-dose regimen has been approved in the age group of 12 years and above
Zydus Cadila to supply 1 crore doses of its Covid-19 vaccine,...
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus
Zydus seeks DCGI’s EUA for world’s first Plasmid DNA based COVID-19...
The company has presented interim results from Phase III clinical trials in over 28,000 volunteers in a study carried out in more than 50 clinical sites spread across the country and during the peak of second wave of COVID-19.......................
Zydus seeks approval to commence Phase III clinical trials of its...
New Delhi: Zydus Cadila has announced that its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D was found to be safe, well tolerated and immunogenic in...
DBT supported & Zydus driven COVID 19 vaccine, ZyCoV-D begins phase...
Vaccine Discovery Programme supported by the Department of Biotechnology, Govt. of India under the National Biopharma Mission, implemented by BIRAC moves into clinical trials The study will assess the safety, tolerability and immunogenicity of the vaccine.................